Literature DB >> 23175790

Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.

Attilio V Vargiu1, Hiroshi Nikaido.   

Abstract

Multidrug resistance in Gram-negative bacteria, to which multidrug efflux pumps such as the AcrB transporter makes a major contribution, is becoming a major public health problem. Unfortunately only a few compounds have been cocrystallized with AcrB, and thus computational approaches are essential in elucidating the interaction between diverse ligands and the pump protein. We used molecular dynamics simulation to examine the binding of nine substrates, two inhibitors, and two nonsubstrates to the distal binding pocket of AcrB, identified earlier by X-ray crystallography. This approach gave us more realistic views of the binding than the previously used docking approach, as the explicit water molecules contributed to the process and the flexible binding site was often seen to undergo large structural changes. We analyzed the interaction in detail in terms of the binding energy, hydrophobic surface-matching, and the residues involved in the process. We found that all substrates tested bound to the pocket, whereas the binding to this site was not preferred for the nonsubstrates. Interestingly, both inhibitors [Phe-Arg-β-naphthylamide and 1-(1-naphtylmethyl)-piperazine] tended to move out of the pocket at least partially, getting into contact with a glycine-rich loop that separates the distal pocket from the more proximal region of the protein and is thought to control the access of substrates to the distal pocket.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175790      PMCID: PMC3528587          DOI: 10.1073/pnas.1218348109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Crystal structure of bacterial multidrug efflux transporter AcrB.

Authors:  Satoshi Murakami; Ryosuke Nakashima; Eiki Yamashita; Akihito Yamaguchi
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

2.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Site-directed disulfide cross-linking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli.

Authors:  Yumiko Takatsuka; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

Review 4.  Flexible ligand docking to multiple receptor conformations: a practical alternative.

Authors:  Maxim Totrov; Ruben Abagyan
Journal:  Curr Opin Struct Biol       Date:  2008-02-25       Impact factor: 6.809

5.  Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Authors:  Jürgen A Bohnert; Sabine Schuster; Eva Fähnrich; Rainer Trittler; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

6.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

7.  Entry into and release of solvents by Escherichia coli in an organic-aqueous two-liquid-phase system and substrate specificity of the AcrAB-TolC solvent-extruding pump.

Authors:  N Tsukagoshi; R Aono
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

Review 8.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.

Authors:  M J Armstrong; M C Carey
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

10.  Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB.

Authors:  Markus A Seeger; Christoph von Ballmoos; Thomas Eicher; Lorenz Brandstätter; François Verrey; Kay Diederichs; Klaas M Pos
Journal:  Nat Struct Mol Biol       Date:  2008-01-27       Impact factor: 15.369

View more
  80 in total

1.  Coarse-grained simulations of conformational changes in the multidrug efflux transporter AcrB.

Authors:  Yead Jewel; Jin Liu; Prashanta Dutta
Journal:  Mol Biosyst       Date:  2017-09-26

2.  Prediction of resistance development against drug combinations by collateral responses to component drugs.

Authors:  Christian Munck; Heidi K Gumpert; Annika I Nilsson Wallin; Harris H Wang; Morten O A Sommer
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

3.  Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.

Authors:  Ketaki Soparkar; Alfred D Kinana; Jon W Weeks; Keith D Morrison; Hiroshi Nikaido; Rajeev Misra
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

Review 4.  Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.

Authors:  Stephanie M Reeve; Michael N Lombardo; Amy C Anderson
Journal:  Future Microbiol       Date:  2015-10-30       Impact factor: 3.165

5.  Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.

Authors:  Alfred D Kinana; Attilio V Vargiu; Hiroshi Nikaido
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

6.  Structures of intermediate transport states of ZneA, a Zn(II)/proton antiporter.

Authors:  John Edward Pak; Elisabeth Ngonlong Ekendé; Efrem G Kifle; Joseph Daniel O'Connell; Fabien De Angelis; Meseret B Tessema; Kheiro-Mouna Derfoufi; Yaneth Robles-Colmenares; Rebecca A Robbins; Erik Goormaghtigh; Guy Vandenbussche; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-30       Impact factor: 11.205

Review 7.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

Review 8.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.

Authors:  Minakshi Puzari; Pankaj Chetia
Journal:  World J Microbiol Biotechnol       Date:  2017-01-02       Impact factor: 3.312

10.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.